Research Article

Nerolidol Suppresses the Inflammatory Response during Lipopolysaccharide-Induced Acute Lung Injury via the Modulation of Antioxidant Enzymes and the AMPK/Nrf-2/HO-1 Pathway

Figure 1

Nerolidol protects against the histopathological exchange of lungs in LPS-induced ALI. (a) Control, (b) LPS, (c) 10 μmol/kg nerolidol+LPS, (d) 30 μmol/kg nerolidol+LPS, (e) 100 μmol/kg nerolidol+LPS, and (f) 1 mg/kg dexamethasone+LPS. Hematoxylin-eosin staining of lung sections of each experimental group (magnification: ; scale bars represent 100 μm). Black arrow, neutrophil infiltration; orange arrow, haemorrhage and hyaline membrane formation; green arrow, alveolar wall thickness and edema.